Skip to content

Customer Interviews

Hear from experts on their experience of using EchoGo Heart Failure and EchoGo Amyloidosis to enhance heart failure management in clinic.

Our Partnership Goals are to: 



  • Help achieve faster and more precise heart failure diagnoses that will improve patient outcomes 
  • Widen our existing knowledge base and increase our expertise on heart failure
  • Continue to speed up AI innovation and scale up our platforms

 



  • Maintain our close connections within the global scientific community
  • Increase inter-industry and academic-industry collaborations

What We Have Achieved with our Partnerships

Published Research and Validation

Through our partnerships with Mayo Clinic, Janssen, and the NHS, we have trained and tested our technology to ensure trust for providers. This technology has gone on to be peer-reviewed in JACC and JASE. 

Reliability in the heart failure sector

With our partners’ continuous support, our technology has proven its reliability through commercial clearances, including three FDA clearances, two CE marks, and two FDA breakthrough designations. 

Access to world-leading science and data

Our technology was built on ten years of outcome data. We were born out of Oxford University from leading minds in science and built in partnership with the U.K.’s National Health Service (NHS).  

We are committed to ongoing partnerships with leading organizations as we seek to achieve continuous improvement of our unparalleled AI technology. 

Building a community of medical and tech experts

We have brought together some of the world’s top experts in both medical science and AI technology to maximize the application of our groundbreaking platform. We’ve built a world-leading Scientific Advisory Board with key industry experts from Northwestern Medicine, Baylor Scott & White, Mayo Clinic, and Harvard Medical Center.

 

What others say about our partnerships:



After Ultromics joined as a full partner The Accelerating Medicines Partnership® Heart Failure (AMP® HF), which includes the National Heart Lung and Blood Institute (NHLBI): 

Implementing EchoGo Heart Failure: An interview with Dr. Andres Schuster

Dr. Andres Schuster discusses his experience with EchoGo Heart Failure at University Hospitals and the Harrington Heart and Vascular Institute. 

Questions?

Ultromics is working closely with providers to establish coverage with commercial players.
For specific reimbursement
questions, please contact us directly.